New Zealand markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
61.79+0.57 (+0.93%)
At close: 4:00PM EDT
61.79 0.00 (0.00%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5185.95B
Enterprise value 3197.81B
Trailing P/E 41.93
Forward P/E 117.27
PEG ratio (5-yr expected) 10.99
Price/sales (ttm)5.36
Price/book (mrq)11.89
Enterprise value/revenue 36.70
Enterprise value/EBITDA 722.53

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 316.43%
S&P500 52-week change 333.64%
52-week high 362.06
52-week low 346.48
50-day moving average 359.00
200-day moving average 357.07

Share statistics

Avg vol (3-month) 36.46M
Avg vol (10-day) 33.85M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 82.62B
% held by insiders 10.03%
% held by institutions 115.18%
Shares short (29 Sep 2021) 47.15M
Short ratio (29 Sep 2021) 41.14
Short % of float (29 Sep 2021) 4N/A
Short % of shares outstanding (29 Sep 2021) 40.23%
Shares short (prior month 30 Aug 2021) 46.41M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 42.29%
Trailing annual dividend rate 32.80
Trailing annual dividend yield 34.57%
5-year average dividend yield 43.49
Payout ratio 497.56%
Dividend date 312 Sep 2021
Ex-dividend date 411 Aug 2021
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 12.77%
Operating margin (ttm)13.41%

Management effectiveness

Return on assets (ttm)3.70%
Return on equity (ttm)25.67%

Income statement

Revenue (ttm)29.53B
Revenue per share (ttm)11.25
Quarterly revenue growth (yoy)31.00%
Gross profit (ttm)21.37B
EBITDA 6.64B
Net income avi to common (ttm)3.77B
Diluted EPS (ttm)1.44
Quarterly earnings growth (yoy)-27.20%

Balance sheet

Total cash (mrq)15.63B
Total cash per share (mrq)5.96
Total debt (mrq)29.89B
Total debt/equity (mrq)190.47
Current ratio (mrq)1.23
Book value per share (mrq)5.97

Cash flow statement

Operating cash flow (ttm)6.45B
Levered free cash flow (ttm)5.87B